sion of human tumor infiltrating lymphocytes for use in immunotherapy 
trials. J. Immunol. Meth. , 102:127-141, 1987. 
30a. Knazek, R. , Wu, Y.W. , Aebersold, P.M. , and Rosenberg, S.A.: Culture of 
human tumor infiltrating lymphocytes in hollow fiber bioreactors. J. 
Immunol. Meth., 127:29-37, 1990. 
31. Cornetta, K. and Anderson, W.F. Protamine sulfate as an effective 
alternative to polybrene in retroviral-mediated gene transfer: 
Implications for human gene therapy. J. Viro. Meth. 23:186-194, 
1989. 
32. Miller, A.D. , and Rosman, G.: Improved retroviral vectors for gene 
transfer and expression. BioTechniques 7:980-990, 1989. 
33. Miller, A.D. and Buttimore, C. : Redesign of retrovirus packaging 
cell line to avoid recombination leading to helper virus 
production. Mol. Cell. Biol. 6:2895-2902, 1986. 
34. Haapala, D.K. , Robey, W.G. , Croszlan, S.D., Tsai, W.P.: Isolation 
from cats of an endogenous type C virus with a novel envelope 
glycoprotein. J. Virol. 53:827-833, 1985. 
35. Armentano, D. , Yu, S.F., Kantoff, P.W. , von Ruden, T. , Anderson, 
W.F., Gilboa, E.: Effect of internal viral sequences on the utility 
of retroviral vectors. J. Virol. 61:1647-1650, 1987. 
36. Cornetta, K. , Moen, R.C., Culver, K. , Morgan, R.A. , McLaclin, J.R., 
Sturm, S., Selegue, J., London, W. , Blaese, R.M. , Anderson, W.F.: 
Amphotropic murine leukemia retrovirus is not an acute pathogen for 
primates. Human Gene Therapy 1:13-26, 1990. 
37. Kantoff, P.W. , Gillio, A.P., McLachlin, J.R., Bordignon, C., Eglitis, 
M.A. , Kernan, N.A. , Moen, R.C., Kohn, D.B. , Yu, S.F., Karson, E. , 
Karlsson, S., Zwiebel, J.A., Gilboa, E. , Blaese, R.M. , Nienhuis, A., 
O'Reilly, R.J., Anderson, W.F.: Expression of human adenosine deaminase 
in nonhuman primates after retrovirus -mediated gene transfer. J. Exp. 
Med. 166:219-234, 1987. 
38. Davies, J. and Smith, D.I.: Plasmid-determined resistance to anti- 
Recombinant DNA Research, Volume 14 
[855] 
